Medication-Assisted Substance Use Treatment Grant

Medication-Assisted Substance Use Treatment Grant

Status: ACTIVE
Funder: Pennsylvania Commission on Crime and Delinquency (PCCD)
Amount: Up to US $250,000
Last Updated: March 04, 2026

Summary

Overview

2026 Medication-Assisted Substance Use Treatment Grant Program Overview: This is a noncompetitive funding announcement open to the 61 counties in Pennsylvania with a county jail. The Pennsylvania Commission on Crime and Delinquency (PCCD) is now accepting applications for funding under the 2026 Medication-Assisted Substance Use Treatment Grant Program. The primary purpose of this funding is to support counties seeking to increase opportunities to provide Medication-Assisted Treatment (MAT), in combination with comprehensive substance use disorder treatment, to eligible offenders who meet the clinical criteria for an opioid use disorder or an alcohol use disorder, as determined by a physician, while incarcerated and upon release from a county jail. For purposes of this funding announcement, the term "Medication-Assisted Treatment" means the use of United States Food and Drug Administration-approved medications (buprenorphine, methadone, and naltrexone/Vivitrol), together with nonmedication treatment, as clinically indicated, to treat substance use disorders, including opioid use disorders and alcohol use disorders. Administration of these medications along with comprehensive substance use disorder treatment will allow newly released participants to focus on immediate reentry needs. Funded counties will adhere to program activities and requirements as discussed in this funding announcement and work collaboratively with local and state partners to ensure effective program operations and successful project outcomes. Successful projects will allow county jails to better equip reentrants as they transition to the community.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.